- Home
- DVAX vs LZ Comparison
DVAX vs LZ Comparison
Compare DVAX & LZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- LZ
- Stock Information
- Founded
- DVAX 1996
- LZ 2001
- Country
- DVAX United States
- LZ United States
- Employees
- DVAX N/A
- LZ N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- LZ EDP Services
- Sector
- DVAX Health Care
- LZ Technology
- Exchange
- DVAX Nasdaq
- LZ Nasdaq
- Market Cap
- DVAX 1.5B
- LZ 1.4B
- IPO Year
- DVAX 2004
- LZ 2021
- Fundamental
- Price
- DVAX $12.21
- LZ $7.73
- Analyst Decision
- DVAX Buy
- LZ Hold
- Analyst Count
- DVAX 2
- LZ 8
- Target Price
- DVAX $22.00
- LZ $7.90
- AVG Volume (30 Days)
- DVAX 3.3M
- LZ 1.2M
- Earning Date
- DVAX 11-07-2024
- LZ 11-06-2024
- Dividend Yield
- DVAX N/A
- LZ N/A
- EPS Growth
- DVAX N/A
- LZ 212.91
- EPS
- DVAX 0.15
- LZ 0.13
- Revenue
- DVAX $260,810,000.00
- LZ $678,838,000.00
- Revenue This Year
- DVAX $23.13
- LZ $6.04
- Revenue Next Year
- DVAX $19.60
- LZ $2.80
- P/E Ratio
- DVAX $80.80
- LZ $59.21
- Revenue Growth
- DVAX N/A
- LZ 4.65
- 52 Week Low
- DVAX $9.74
- LZ $5.33
- 52 Week High
- DVAX $15.01
- LZ $13.74
- Technical
- Relative Strength Index (RSI)
- DVAX 52.22
- LZ 53.39
- Support Level
- DVAX $11.61
- LZ $7.06
- Resistance Level
- DVAX $13.74
- LZ $9.31
- Average True Range (ATR)
- DVAX 0.52
- LZ 0.32
- MACD
- DVAX 0.09
- LZ 0.00
- Stochastic Oscillator
- DVAX 32.80
- LZ 31.07
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About LZ LegalZoom.com Inc.
LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.